Walking and socializing may protect brain health in HIV+ latinos
NCT ID NCT04791709
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a program called HOLA (Happy Older Latinos are Active) in 30 Latino adults aged 50+ living with HIV. The program included one-on-one sessions with a community health worker, group walks three times a week, and planning pleasant activities. The goal was to see if this approach could help prevent cognitive decline and was practical for participants to complete.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Happy Older Latinos are Active (HOLA) program
- What this could lead to
- If successful, this program could offer a practical, community-based way to help older Latino adults with HIV maintain their memory and thinking skills.
- What could go wrong
- This was a small, early feasibility study with only 30 participants, so results may not apply to larger or more diverse groups. The program requires regular group walks and one-on-one sessions, which may be hard to sustain long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Feb 2022
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * are Latino (self-identified); * are age 50+; * are HIV infected but are virologically suppressed (viral load \<200 copies/mL); * volunteer informed consent Exclusion Criteria: * have diagnosis of any neurodegenerative disorder or dementia (Parkinson's disease, Alzheimer's disease, vascular, frontotemporal dementia, etc.) or significant cognitive impairment as indicated by a Telephone Interview for Cognitive Status (TICS) score less than or equal to 30; * have other conditions that could impact cognitive functioning or testing (e.g., legally blind or deaf), currently undergoing radiation or chemotherapy, a history of brain trauma with a loss of consciousness greater than 30 minutes. * have contraindications to physical activity outlined in the American College of Sports Medicine standards or severe medical illness that precludes them from safely participating in a health promotion intervention. * are unable to complete 10-meter walk test. * have plans to move outside of the Miami metropolitan area within the next 6 months or are not living in stable housing (e.g. group home).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cognitive decline are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Miami
Miami, Florida, 33136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can brain training rewire the MS brain? study probes cognitive decline
- Can remote counseling help people with HIV cut back on alcohol?
- Can a Once-Daily HIV pill with food match Twice-Daily dosing during TB treatment?
- Four weeks vs twelve weeks: can a shorter TB prevention course work?
- Can a phone app keep young people with HIV engaged in care?
- Massive Real-World database aims to map how chronic diseases interact